DNV, the independent global assurance and risk management provider, is partnering with Korean AI-driven blood and cancer ...
A generative AI system can now analyze blood cells with greater accuracy and confidence than human experts, detecting subtle signs of diseases like leukemia. It not only spots rare abnormalities but ...
Stocktwits on MSN
Why did WOK stock surge over 50% today?
The system combines advanced imaging with AI software to analyze blood smears, conduct white blood cell counts, and assess red blood cells and platelets. ・The company expects to begin manufacturing ...
WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co.
WORK Medical’s subsidiary Hunan Saitumofei receives manufacturing approval for its Class II medical devices: Hangzhou, China Wednesday, December 31, 2025, 15:00 Hrs [IST] WORK M ...
DNV is a trusted Notified Body for medical device certification under the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). We provide independent, rigorous, and ...
Technology Group, through its subsidiary, Work Medical Treatment Equipment Co., announced that its subsidiary, Hunan Saitumofei ...
An AI tool that can analyse abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the way conditions such as leukaemia are ...
What To Know: The Hunan Provincial Medical Products Administration approved manufacturing for Work Medical’s Class II medical device, an artificial intelligence automated human blood cell morphology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback